ESSEX INVESTMENT MANAGEMENT CO LLC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 70 filers reported holding RECRO PHARMA INC in Q4 2020. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
ESSEX INVESTMENT MANAGEMENT CO LLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q1 2022$1,440,000
+10.4%
799,841
+4.9%
0.18%
+20.1%
Q4 2021$1,304,000
-10.3%
762,794
+8.2%
0.15%
-16.3%
Q3 2021$1,453,000
+46.5%
705,219
+64.3%
0.18%
+54.8%
Q2 2021$992,000
-23.9%
429,327
-8.1%
0.12%
-27.7%
Q1 2021$1,303,000
+362.1%
466,992
+371.5%
0.16%
+354.3%
Q4 2020$282,000
-56.3%
99,046
-30.2%
0.04%
-67.0%
Q2 2020$646,000
-44.5%
141,908
-0.5%
0.11%
-55.1%
Q1 2020$1,165,000
-57.7%
142,608
-5.1%
0.24%
-30.4%
Q4 2019$2,755,000
+30.1%
150,303
-21.4%
0.34%
+10.8%
Q3 2019$2,118,000
-2.2%
191,117
-10.3%
0.31%
+3.0%
Q2 2019$2,166,000
+46.9%
213,002
-15.3%
0.30%
+36.2%
Q1 2019$1,474,000
-59.7%
251,464
-51.2%
0.22%
-24.0%
Q4 2018$3,660,000
+103.6%
515,414
+103.8%
0.29%
+36.0%
Q3 2018$1,798,000
+145.6%
252,874
+73.5%
0.21%
+129.3%
Q2 2018$732,000
-54.3%
145,749
+0.1%
0.09%
-56.4%
Q1 2018$1,603,000
+87.3%
145,614
+57.3%
0.21%
+86.7%
Q4 2017$856,000
+2.3%
92,565
-0.7%
0.11%
-0.9%
Q3 2017$837,000
+79.2%
93,199
+40.3%
0.11%
+70.1%
Q2 2017$467,000
-43.7%
66,414
-30.0%
0.07%
-48.5%
Q1 2017$830,000
-0.6%
94,911
-8.4%
0.13%
-5.8%
Q4 2016$835,000103,6160.14%
Other shareholders
RECRO PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders